CLOV — Clover Health Investments Share News
0.000.00%
Last trade - 00:00- $2.63bn
- $2.43bn
- $1.92bn
Brief: Clover Health Says In Payment Year 2026,Sees To Experience General 5% Quality Bonus Increase In Benchmark Rates Due To Ppo Contract Being Rated 4.0 Stars
Brief: Clover Health Ppo Medicare Advantage Plans Earn 4 Star Rating For 2025
Brief: Counterpart Health Names David Tsay As Chief Medical Officer
Brief: Clover Health Says SEC Concluded Its Investigation Of Co Commenced In February 2021
Brief: The Iowa Clinic Signs Multi-Year Agreement With Counterpart Health
U.S. RESEARCH ROUNDUP- Actinium Pharmaceuticals, Albemarle, ArcBest
Clover Health Investments Corp reports results for the quarter ended in June - Earnings Summary
Brief: Clover Health Investments Q2 Revenue USD 349.9 Million
Clover Health Investments Corp expected to post a loss of 5 cents a share - Earnings Preview
Brief: CMS Improves Star Ratings To 3.5 Stars For Clover Health Ppo Medicare Advantage Plans For 2025 Payment Year
Clover Health Investments Corp reports results for the quarter ended in March - Earnings Summary
Brief: Clover Health Investments Authorizes Share Repurchase Program Of Up To $20 Mln Of Company's Class A Common Stock Over Next Two Years
Brief: Clover Health Investments Q1 Revenue USD 346.9 Million
Clover Health Investments Corp expected to post a loss of 7 cents a share - Earnings Preview
Brief: Clover Health Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Clover Health Appoints Healthcare Technology Veteran Peter Kuipers As Chief Financial Officer
Brief: Clover Health Investments Receives Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Clover Health Investments Corp reports results for the quarter ended in December - Earnings Summary
Brief: Clover Health Investments Q4 Revenue USD 510.3 Million